Exhibit 1.1

Certificate of Continuance	Certificat de prorogation
Canada Business Corporations Act	Loi canadienne sur les sociétés par actions

Medicenna Therapeutics Corp.

Corporation number / Numéro de société

1049266-3

Corporation number / Numéro de société

I HEREBY CERTIFY that the above-named corporation, the articles of continuance of which are attached, is continued under section 187 of the Canada Business Corporations Act (CBCA). JE CERTIFIE que la société susmentionnée, dont les clauses de prorogation sont jointes, est prorogée en vertu de l'article 187 de la Loi canadienne sur les sociétés par actions (LCSA).

Virginia Ethier

Director / Directeur

2017-11-13

Date of Continuance (YYYY-MM-DD)
Date de prorogation (AAAA-MM-JJ)

Form 11 Articles of Continuance	Formulaire 11 Clauses de prorogation
Canada Business Corporations Act (CBCA) (s. 187)	Loi canadienne sur les sociétés par actions (LCSA) (art. 187)

1	Corporate name Dénomination sociale Medicenna Therapeutics Corp.
2	The province or territory in Canada where the registered office is situated La province ou le territoire au Canada où est situé le siège social ON
3	The classes and the maximum number of shares that the corporation is authorized to issue Catégories et le nombre maximal d’actions que la société est autorisée à émettre See attached schedule / Voir l'annexe ci-jointe
4	Restrictions on share transfers Restrictions sur le transfert des actions None
5	Minimum and maximum number of directors Nombre minimal et maximal d’administrateurs Min. 1 Max. 11
6	Restrictions on the business the corporation may carry on Limites imposées à l’activité commerciale de la société None
7	(1) If change of name effected, previous name S’il y a changement de dénomination sociale, indiquer la dénomination sociale antérieure Not Applicable / Sans objet
	(2) Details of incorporation Détails de la constitution Certificate of Incorporation dated February 2, 2015 Certificate of Amendment dated March 1, 2017
8	Other Provisions Autres dispositions See attached schedule / Voir l'annexe ci-jointe
9	Declaration: I certify that I am a director or an officer of the company continuing into the CBCA. Déclaration : J’atteste que je suis un administrateur ou un dirigeant de la société se prorogeant sous le régime de la LCSA.

Original signed by / Original signé par

Elizabeth Williams

Elizabeth Williams

Misrepresentation constitutes an offence and, on summary conviction, a person is liable to a fine not exceeding $5000 or to imprisonment for a term not exceeding six months or both (subsection 250(1) of the CBCA).

Faire une fausse déclaration constitue une infraction et son auteur, sur déclaration de culpabilité par procédure sommaire, est passible d’une amende maximale de 5 000 $ et d’un emprisonnement maximal de six mois, ou l’une de ces peines (paragraphe 250(1) de la LCSA).

You are providing information required by the CBCA. Note that both the CBCA and the Privacy Act allow this information to be disclosed to the public. It will be stored in personal information bank number IC/PPU-049.

Vous fournissez des renseignements exigés par la LCSA. Il est à noter que la LCSA et la Loi sur les renseignements personnels permettent que de tels renseignements soient divulgués au public. Ils seront stockés dans la banque de renseignements personnels numéro IC/PPU-049.

IC 3247 (2008/04)

Schedule / Annexe

Description of Classes of Shares / Description des categories d'action

An unlimited number of Common shares and an unlimited number of Preferred shares.

The rights, privileges, restrictions and conditions attached to the Common shares and the Preferred shares shall be as follows:

1.  Common shares, the holders of which are entitled:

(a)              to receive notice of and to attend and vote at all meetings of shareholders, except meetings at which only holders of a specified class of shares are entitled to vote;

(b)              to receive any dividend declared by the Corporation on this class of shares; provided that the Corporation shall be entitled to declare dividends on the Preferred shares, or on any of such classes of shares without being obliged to declare any dividends on the Common shares of the Corporation;

(c)              subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of the Corporation, to receive the remaining property of the Corporation upon dissolution in equal rank with the holders of all other Common shares of the Corporation; and

(d)              to the rights, privileges and restrictions normally attached to common shares;

2.  Preferred shares, which as a class, have attached thereto the following rights, privileges, restrictions and conditions:

(a)              the Preferred shares may from time to time be issued in one or more series, and the Directors may fix from time to time before such issue the number of Preferred shares which is to comprise each series and the designation, rights, privileges, restrictions and conditions attaching to each series of Preferred shares including, without limiting the generality of the foregoing, any voting rights, the rate or amount of dividends or the method of calculating dividends, the dates of payment thereof, the terms and conditions of redemption, purchase and conversion if any, and any sinking fund or other provisions;

(b)              the Preferred shares of each series shall, with respect to the payment of dividends and the distribution of assets or return of capital in the event of liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or any other return of capital or distribution of the assets of the Corporation amongst its shareholders for the purpose of winding up its affairs, be entitled to preference over the voting and non-voting Common shares and over any other shares of the Corporation ranking by their terms junior to the Preferred shares of that series. The Preferred shares of any series may also be given such other preferences, not inconsistent with these Articles over the Common shares and any other such Preferred shares as may be fixed in accordance with clause (2)(a); and

(c)               if any cumulative dividends or amounts payable on the return of capital in respect of a series of Preferred shares are not paid in full, all series of Preferred shares shall participate rateably in respect of accumulated dividends and return of capital.

Schedule / Annexe

Other Provisions / Autres dispositions

Other provisions:

(a)         The Directors may, between Annual General Meetings, appoint 1 or more additional Directors of the Corporation to serve until the next Annual General Meeting, but the number of additional Directors shall not at any time exceed 1/3 of the number of Directors who held office at the expiration of the last Annual Meeting of the Corporation.

(b)         Meetings of shareholders of the Corporation shall be held anywhere inside or outside of Canada that the directors determine.

CORPORATE ACCESS NUMBER: 2018755179

Government
of Alberta ■

BUSINESS CORPORATIONS ACT

CERTIFICATE

OF

AMENDMENT

MEDICENNA THERAPEUTICS CORP.

AMENDED ITS ARTICLES ON 2017/03/01.

BUSINESS CORPORATIONS ACT
(Section 29 or 177)

ALBERTA CORPORATE REGISTRY    1          Name of Corporation               A2 ACQUISITION CORP.    ARTICLES OF AMENDMENT   2.         Corporate Access Number               2018755179  

The Articles of the above-named corporation are amended as follows:

1.  Pursuant to Section 173(1)(f) of the Business Corporations Act (Alberta) (the “Act”), the Articles of the Corporation are hereby amended to change the number of issued and outstanding Common shares of the Corporation into a different number of shares of the same Class on the basis of one (1) Common share for each fourteen (14) Common shares currently issued and outstanding; and

2. Pursuant to Section 173(1)(a) of the Act, the Corporation be and is hereby authorized to amend the Articles of the Corporation to change the name of the Corporation from A2 Acquisition Corp. to:

Medicenna Therapeutics Corp.

Date: 2017/02/_____________ Signature:/s/                                                       Title: _______________________________

For Departmental Use Only:     Filed

Section 173(1)(f) Schedule

All issued and outstanding Common shares in the capital of the Corporation are hereby converted on the basis of 1 Common share for each 14 Common shares currently issued and outstanding.

CAN: 23744522.1

Name/Structure Change Alberta Corporation - Registration Statement

Alberta Amendment Date: 2017/03/01

Service Request Number:	26619045
Corporate Access Number:	2018755179
Legal Entity Name:	A2 ACQUISITION CORP.
French Equivalent Name:
Legal Entity Status:	Active

Alberta Corporation Type:	Named Alberta Corporation
New Legal Entity Name:	MEDICENNA THERAPEUTICS CORP.
New French Equivalent Name:
Nuans Number:	120113990
Nuans Date:	2016/12/07
French Nuans Number:
French Nuans Date:

Share Structure:	SCHEDULE “A” A 1 1ACHED
Share Transfers Restrictions:	NONE
Number of Directors:
Min Number Of Directors:	1
Max Number Of Directors:	11
Business Restricted To:	NONE
Business Restricted From:	NONE
Other Provisions:	SCHEDULE “B” ATTACHED
BCA Section/Subsection:	173(1)(A)(F)

Professional Endorsement Provided:

Future Dating Required:        

Annual Return

File Year	Date Filed
2016	2016/04/13

Attachment

Attachment Type	Microfilm Bar Code	Date Recorded
Other Rules or Provisions	ELECTRONIC	2015/02/02
Share Structure	ELECTRONIC	2015/02/02
Consolidation, Split, Exchange	ELECTRONIC	2017/03/01

Registration Authorized By:	TREVOR WONG-CHOR
	SOLICITOR

CORPORATE ACCESS NUMBER:  2018755179

Government
of Alberta ■

BUSINESS CORPORATIONS ACT

CERTIFICATE

OF

INCORPORATION

A2 ACQUISITION CORP.

WAS INCORPORATED IN ALBERTA ON 2015/02/02.

Articles of Incorporation
For
A2 ACQUISITION CORP.

Share Structure:	SCHEDULE “A” ATTACHED
Share Transfers Restrictions:	NONE
Number of Directors:
Min Number of Directors:	1
Max Number of Directors:	11
Business Restricted To:	NONE
Business Restricted From:	NONE
Other Provisions:	SCHEDULE “B” ATTACHED

Registration Authorized By:	TREVOR WONG-CHOR
	SOLICITOR

SCHEDULE “A”

THE CLASSES OF SHARES AND ANY MAXIMUM NUMBER OF SHARES THAT THE CORPORATION IS AUTHORIZED TO ISSUE ARE:

1.           An unlimited number of Common shares, the holders of which are entitled:

(a)         to receive notice of and to attend and vote at all meetings of shareholders, except meetings at which only holders of a specified class of shares are entitled to vote;

(b)        to receive any dividend declared by the Corporation on this class of shares; provided that the Corporation shall be entitled to declare dividends on the Preferred shares, or on any of such classes of shares without being obliged to declare any dividends on the Common shares of the Corporation;

(c)         subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of the Corporation, to receive the remaining property of the Corporation upon dissolution in equal rank with the holders of all other Common

shares of the Corporation; and

(d)         to the rights, privileges and restrictions normally attached to common shares;

2.           An unlimited number of Preferred shares, which as a class, have attached thereto the following rights, privileges, restrictions and conditions:

(a)        the Preferred shares may from time to time be issued in one or more series, and the Directors may fix from time to time before such issue the number of Preferred shares which is to comprise each series and the designation, rights, privileges, restrictions and conditions attaching to each series of Preferred shares including, without limiting the generality of the foregoing, any voting rights, the rate or amount of dividends or the method of calculating dividends, the dates of payment thereof, the terms and conditions of redemption, purchase and conversion if any, and any sinking fund or other provisions;

(b)         the Preferred shares of each series shall, with respect to the payment of dividends and the distribution of assets or return of capital in the event of liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or any other return of capital or distribution of the assets of the Corporation amongst its shareholders for the purpose of winding up its affairs, be entitled to preference over the voting and non-voting Common shares and over any other shares of the Corporation ranking by their terms junior to the Preferred shares of that series. The Preferred shares of any series may also be given such other preferences, not inconsistent with these Articles, over the Common shares and any other such Preferred shares as may be fixed in accordance with clause (2)(a); and

(c)          if any cumulative dividends or amounts payable on the return of capital in respect of a series of Preferred shares are not paid in full, all series of Preferred shares shall participate rateably in respect of accumulated dividends and return of capital.

SCHEDULE “B”

Attached to and forming part of the Articles of Incorporation

OTHER RULES OR PROVISIONS (IF ANY):

(a)         The Directors may, between Annual General Meetings, appoint 1 or more additional Directors of the Corporation to serve until the next Annual General Meeting, but the number of additional Directors shall not at any time exceed 1/3 of the number of Directors who held office at the expiration of the last Annual Meeting of the Corporation.

(b)         Meetings of shareholders of the Corporation shall be held anywhere inside or outside of Canada that the directors determine.

Incorporate Alberta Corporation - Registration Statement

Alberta Registration Date: 2015/02/02

Corporate Access Number: 2018755179

Service Request Number:	22744734
Alberta Corporation Type:	Named Alberta Corporation
Legal Entity Name:	A2 ACQUISITION CORP.
French Equivalent Name:
Nuans Number:	114569861
Nuans Date:	2015/01/30
French Nuans Number:
French Nuans Date:

REGISTERED ADDRESS
Street:	1000, 250 – 2ND STREET SW
Legal Description:
City:	CALGARY
Province:	ALBERTA
Postal Code:	T2P 0C1

RECORDS ADDRESS
Street:	1000, 250 – 2ND STREET SW
Legal Description:
City:	CALGARY
Province:	ALBERTA
Postal Code:	T2P 0C1

ADDRESS FOR SERVICE BY MAIL

Post Office Box:

City:

Province:   

Postal Code:

Internet Mail ID:

Share Structure:	SCHEDULE “A” ATTACHED
Share Transfers Restrictions:	NONE
Number of Directors:
Min Number Of Directors:	1
Max Number Of Directors:	11

Business Restricted To:	NONE
Business Restricted From:	NONE
Other Provisions:	SCHEDULE “B” ATTACHED

Professional Endorsement Provided:
Future Dating Required:
Registration Date:	2015/02/02

Director
Last Name:	DEMICHELE
First Name:	GINO
Middle Name:
Street/Box Number:	23 ALEXA CLOSE
City:	CALGARY
Province:	ALBERTA
Postal Code:	T3R 1B9
Country:
Resident Canadian:	Y

Last Name:	MCLEAN
First Name:	GREG
Middle Name:
Street/Box Number:	2640 - 5TH AVENUE NW
City:	CALGARY
Province:	ALBERTA
Postal Code:	T2N OT6
Country:
Resident Canadian:	Y

Last Name:	ANDERSON
First Name:	GORDON
Middle Name:	D.
Street/Box Number:	#404, 3412 PARKDALE BOULEVARD NW
City:	CALGARY
Province:	ALBERTA
Postal Code:	T2N 3T4
Country:
Resident Canadian:	Y

Attachment

Attachment Type	Microfilm Bar Code	Date Recorded
Share Structure	ELECTRONIC	2015/02/02
Other Rules or Provisions	ELECTRONIC	2015/02/02

Registration Authorized By:	TREVOR WONG-CHOR
	SOLICITOR

Articles Of Incorporation

Business Corporations Act

Section 6

1.	Name of Corporation
	A2 ACQUISITION CORP.
2.	The classes of shares, and any maximum number of shares that the corporation is authorized to issue: SCHEDULE “A” ATTACHED
3.	Restrictions on share transfers (if any): NONE
4.	Number, or minimum and maximum number, of directors that the corporation may have: Minimum 1; Maximum 11
5.	If the corporation is restricted FROM carrying on a certain business, or restricted TO carrying on a certain business, specify the restriction(s): NONE
6.	Other rules or provisions (if any): SCHEDULE “B” ATTACHED
7.	Date authorized by Incorporators:                  2015 / 02 / 02                                                                                   Year/ Month / Day

Incorporators

Name of Person Authorizing (please print)	Address: (including postal code)	Signature
		/s/

This information is being collected for the purposes of corporate registry records in accordance with the Business Corporations Act. Questions about the collection of this information can be directed to the Freedom of Information and Protection of Privacy Coordinator, Box 3140, Edmonton, Alberta T5J 4L4, (780) 427-7013.

REG 3047 (Rev. 2003/05)

SCHEDULE “A”

Attached to and forming part of the Articles of Incorporation

THE CLASSES OF SHARES AND ANY MAXIMUM NUMBER OF SHARES THAT THE CORPORATION IS AUTHORIZED TO ISSUE ARE:

1.         An unlimited number of Common shares, the holders of which are entitled:

(a)          to receive notice of and to attend and vote at all meetings of shareholders, except meetings at which only holders of a specified class of shares are entitled to vote;

(b)         to receive any dividend declared by the Corporation on this class of shares; provided that the Corporation shall be entitled to declare dividends on the Preferred shares, or on any of such classes of shares without being obliged to declare any dividends on the Common shares of the Corporation;

(c)         subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of the Corporation, to receive the remaining property of the Corporation upon dissolution in equal rank with the holders of all other Common shares of the Corporation; and

(d)         to the rights, privileges and restrictions normally attached to common shares;

2.         An unlimited number of Preferred shares, which as a class, have attached thereto the following rights, privileges, restrictions and conditions:

(a)          the Preferred shares may from time to time be issued in one or more series, and the Directors may fix from time to time before such issue the number of Preferred shares which is to comprise each series and the designation, rights, privileges, restrictions and conditions attaching to each series of Preferred shares including, without limiting the generality of the foregoing, any voting rights, the rate or amount of dividends or the method of calculating dividends, the dates of payment thereof, the terms and conditions of redemption, purchase and conversion if any, and any sinking fund or other provisions;

(b)         the Preferred shares of each series shall, with respect to the payment of dividends and the distribution of assets or return of capital in the event of liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or any other return of capital or distribution of the assets of the Corporation amongst its shareholders for the purpose of winding up its affairs, be entitled to preference over the voting and non-voting Common shares and over any other shares of the Corporation ranking by their terms junior to the Preferred shares of that series. The Preferred shares of any series may also be given such other preferences, not inconsistent with these Articles, over the Common shares and any other such Preferred shares as may be fixed in accordance with clause (2)(a); and

(c)         if any cumulative dividends or amounts payable on the return of capital in respect of a series of Preferred shares are not paid in full, all series of Preferred shares shall participate rateably in respect of accumulated dividends and return of capital.

SCHEDULE “B”

Attached to and forming part of the Articles of Incorporation

OTHER RULES OR PROVISIONS (IF ANY):

(a)          The Directors may, between Annual General Meetings, appoint 1 or more additional Directors of the Corporation to serve until the next Annual General Meeting, but the number of additional Directors shall not at any time exceed 1/3 of the number of Directors who held office at the expiration of the last Annual Meeting of the Corporation.

(b)         Meetings of shareholders of the Corporation shall be held anywhere inside or outside of Canada that the directors determine.